Table 2.
Score range | Total (n = 147) | AD-preventive behaviors related to medicines | ||||||
---|---|---|---|---|---|---|---|---|
Intention to take AD-preventive medicines | Experience of taking Gingko biloba or similar medicines | |||||||
Yes (n = 139) | No (n = 8) | P value | Yes (n = 68) | No (n = 79) | P value | |||
HBM variables | ||||||||
Total score | 30-150 | 106.6 (11.0) | 107.2 (10.7) | 97.1 (12.0) | .012† | 108.7 (10.8) | 104.8 (10.8) | .029† |
Perceived susceptibility | 4-20 | 12.9 (3.6) | 13.0 (3.5) | 10.6 (3.7) | .068† | 13.7 (3.5) | 12.2 (3.5) | .010† |
Perceived severity | 4-20 | 15.7 (2.8) | 15.7 (2.7) | 14.3 (3.3) | .142† | 16.0 (2.8) | 15.3 (2.8) | .143† |
Perceived benefits | 4-20 | 16.5 (2.4) | 16.5 (2.4) | 15.5 (2.5) | .247† | 16.8 (2.4) | 16.2 (2.5) | .172† |
Perceived barriers | 11-55 | 34.9 (6.4) | 34.9(6.5) | 34.6 (4.2) | .914† | 34.6 (6.6) | 35.1 (6.3) | .630† |
Self-efficacy | 7-35 | 26.8 (4.5) | 27.0 (4.4) | 22.1 (4.8) | .003† | 27.7 (4.4) | 26.0 (4.5) | .020† |
Cue to action | 5-25 | 12.7 (3.4) | 12.8 (3.5) | 10.8 (2.0) | .096† | 13.8 (3.7) | 11.8 (3.0) | .000† |
Non-HBM variables | ||||||||
Knowledge of dementia | 0-12 | 9.7 (1.3) | 9.7 (1.2) | 8.13 (1.4) | .001† | 9.7 (1.2) | 9.6 (1.3) | .518† |
Values are presented as mean (SD).
t test
AD = Alzheimer’s disease, HBM = health belief model, MCI = mild cognitive impairment, SD = standard deviation.